ArticleNeuroepidemiology2026
Salivary Testosterone Concentration and Cognitive Impairment among Japanese Older Adults in the Toon Health Study.
Article in Neuroepidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAs the number of people with mild cognitive impairment (MCI) increases, modifiable risk factors, such as stress and an unhealthy lifestyle, and preventative measures are gaining interest. However, evidence for an association between potential biomarkers of such risk factors and MCI is limited. The study aimed to investigate the association between the salivary testosterone concentration and MCI in Japanese community-dwelling older adults.
methodsThis cross-sectional study involved 359 participants (159 men and 200 women) aged 60 years and over. MCI was evaluated using the Japanese version of the Montreal Cognitive Assessment; a score <26 was deemed indicative of MCI. A saliva sample was collected after the patient chewed sugar-free gum for 5 min in the morning, and the salivary testosterone concentrations were assayed. A modified Poisson regression model was used to examine the association between the salivary testosterone concentration and MCI after adjusting for age, body mass index, hypertension, diabetes mellitus, alcohol intake, smoking status, physical activity, sleep hours, and age at menopause (women only).
resultsFor women, the multivariable-adjusted prevalence ratio (PR; 95% confidence interval [CI]) of MCI for the highest-quartile group of salivary testosterone concentrations compared with the lowest-quartile group was 0.52 (0.26, 1.04), and the multivariable-adjusted PR (95% CI) for 1-standard deviation increments of log-transformed salivary testosterone concentrations was 0.74 (0.61, 0.89). A similar trend was found in men, but it was not statistically significant.
conclusionThis study of Japanese individuals aged 60 years or older provides important evidence that a higher salivary testosterone concentration is associated with lower prevalence of MCI and higher cognitive function in women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.